✦ LIBER ✦

The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma

✍ Scribed by H. Mellstedt; J. E. Frödin; P. Ragnhammar; G. Masucci; J. Shetye; B. Christensson; P. Biberfeld; J. Makower; P. Pihlstedt; B. Cedermark; U. Harmenberg; B. Wahren; Å. Rieger; I. Magnusson; J. Nathansson; R. Erwald

Book ID: 112962902
Publisher: Springer US
Year: 1989
Tongue: English
Weight: 890 KB
Volume: 6
Category: Article
ISSN: 1357-0560
DOI: 10.1007/bf02985230

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The therapeutic use of the unconjugated

The therapeutic use of the unconjugated monoclonal antibodies (MAb) 17-1a in combination with GM-CSF in the treatment of COLORECTAL CARCINOMA (CRC)

✍ P. Ragnhammar; I. Magnusson; G. Masucci; H. Mellstedt 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 916 KB

Clinical experience with monoclonal anti

Clinical experience with monoclonal antibodies alone. Treatment of col0-rectal carcinomas with Mab 17-1A AND T CELL MALIGNANCIES WITH anti-idiotypic antibodies

✍ H→kan Mellstedt; P. Biberfeld; B. Christensson; J.-E. Frödin; C.H. Janson; J. Sh 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Monoclonal antibodies in the treatment o

Monoclonal antibodies in the treatment of metastatic colorectal cancer: A review

✍ Jolien Tol; Cornelis J.A. Punt 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 875 KB

Clinical effects of monoclonal antibody

Clinical effects of monoclonal antibody 17-1A combined with granulocyte/macrophage-colony-stimulating factor and interleukin-2 for treatment of patients with advanced colorectal carcinoma

✍ A.-L. Hjelm Skog; P. Ragnhammar; J. Fagerberg; J.-E. Frödin; M. Goldinger; H. Ko 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 215 KB

Bevacizumab in the Treatment of a Patien

Bevacizumab in the Treatment of a Patient with Metastatic Colorectal Carcinoma with Brain Metastases

✍ Achala Bhaskara; Cathy Eng 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 563 KB

Natural killer (NK) cell function is a s

Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A

✍ Maria Liljefors; Bo Nilsson; Anna-Lena Hjelm Skog; Peter Ragnhammar; Håkan Mells 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 106 KB

## Abstract Tumor cells might be susceptible to different effector functions of the immune system. This cytotoxic capacity has been utilized to analyze the prognostic significance of peripheral blood mononuclear cells (PBMC) in patients with metastatic colorectal carcinoma (CRC) treated with the mo